Today: Patient Identification and the Chair-Side Conversation

Today: Patient Identification and the Chair-Side Conversation

Join Jacob Lang, OD, FAAO, for 30 minutes on who’s a good fit for pharmacologic presbyopia treatment and how to start that conversation. Get a data-backed framework covering refractive status, ocular surface health, pupil dynamics, and lifestyle, plus the safety considerations and contraindications that matter most. Plus, earn up to 0.5 free CE hours!

New Content
24-Month ELIOS Data: IOP, Medication, and Safety Outcomes
Clinical Studies & Trials
24-Month ELIOS Data: IOP, Medication, and Safety Outcomes
November 12, 2026
Systems That Keep Patients Buying Lenses In-House
Practice Metrics & Analytics
Systems That Keep Patients Buying Lenses In-House
November 12, 2026
Recently Published
Remigromig in DME: What BRUNELLO Shows and What BAROLO Must Answer
CLINICAL STUDIES & TRIALS
Remigromig in DME: What BRUNELLO Shows and What BAROLO Must Answer

Join Drs. Rishi Singh and Donald D'Amico to review the results of the phase 3 BRUNELLO trial of Remigromig for DME and implications for the BAROLO trial.

2026 Optometrist Report
OPTOMETRY INDUSTRY INFO
2026 Optometrist Report

Download the free report to understand how optometrists today are advancing their careers, managing their practices, and adapting to evolving trends in eyecare.

Natalie Osayande, OD, MSNovember 9, 2026
Barriers to Oculomics and How to Overcome Them
PRODUCTS & TECHNOLOGY
Barriers to Oculomics and How to Overcome Them

Consider key challenges in the adoption and implementation of oculomics, such as settling regulatory, legal, and reimbursement questions, and more.

Matlock Wyman, ODNovember 6, 2026
Stabilizing the Tear Film Prior to Cataract Surgery

Stabilizing the Tear Film Prior to Cataract Surgery

Sit down with Drs. Preeya K. Gupta and Vance Thompson to review approaches for efficiently addressing tear film instability before cataract surgery.

Learn More
Latest Stories
VeonGen on track for phase 3 Stargardt trial after FDA meeting
November 12, 2026
VeonGen on track for phase 3 Stargardt trial after FDA meeting

Phase 1/2 trial data demonstrate favorable safety profile and BCVA improvements; company has met with the FDA to plan the phase 3 program.

Scope launches OPTASE Heat Mask Pro for dry eye relief
November 12, 2026
Scope launches OPTASE Heat Mask Pro for dry eye relief

New addition to the OPTASE product line of dry eye management solutions delivers targeted and symptomatic relief via Hydrobead moist heat technology.

Newton launches all-in-one OD program, refreshes Founders Optical brand
November 11, 2026
Newton launches all-in-one OD program, refreshes Founders Optical brand

Newton Preferred program offers technology, lenses, frames, financing, and pricing in a single vision care program for independent practices.

Clinical
24-Month ELIOS Data: IOP, Medication, and Safety Outcomes
CLINICAL STUDIES & TRIALS
24-Month ELIOS Data: IOP, Medication, and Safety Outcomes

Sit down with Drs. Mark Gallardo and Steven Sarkisian to review 24-month findings from the pivotal trial for ELIOS combined with cataract surgery.

A Concise Workflow for Identifying and Monitoring Glaucoma Suspects
CLINICAL GUIDES
A Concise Workflow for Identifying and Monitoring Glaucoma Suspects

Review step by step pearls for diagnosing and managing glaucoma suspects, and how a shift toward earlier procedural intervention is reducing drop burden.

Nick Bruns, OD, FAAONovember 11, 2026
Remigromig in DME: What BRUNELLO Shows and What BAROLO Must Answer
CLINICAL STUDIES & TRIALS
Remigromig in DME: What BRUNELLO Shows and What BAROLO Must Answer

Join Drs. Rishi Singh and Donald D'Amico to review the results of the phase 3 BRUNELLO trial of Remigromig for DME and implications for the BAROLO trial.

Careers
Systems That Keep Patients Buying Lenses In-House
PRACTICE METRICS & ANALYTICS
Systems That Keep Patients Buying Lenses In-House

Consider approaches optometrists can take to increase the number of patients who purchase contact lenses at the office instead of online retailers.

2026 Optometrist Report
OPTOMETRY INDUSTRY INFO
2026 Optometrist Report

Download the free report to understand how optometrists today are advancing their careers, managing their practices, and adapting to evolving trends in eyecare.

Natalie Osayande, OD, MSNovember 9, 2026
How DTC Advertising is Driving Presbyopia Drop Conversations in Practice
PRESBYOPIA
How DTC Advertising is Driving Presbyopia Drop Conversations in Practice

Joins Drs. Coats, Davison, Ramsey and Schaeffer to review how direct-to-consumer (DTC) advertising impacts patient conversations about presbyopia drops.

Sponsored Content
The Ultimate Guide to TOTAL30® Multifocal for Astigmatism
PRIMARY CARE

The Ultimate Guide to TOTAL30® Multifocal for Astigmatism

Drs. Cifuentes and Lagunas offer insight into TOTAL30® Multifocal for Astigmatism, a modern solution designed for presbyopic patients with astigmatism, providing comfort and clear vision for both distance and near tasks.1

Our industry partners

ZEISS
National Vision
EssilorLuxottica
Essilor
Johnson & Johnson Vision
ZEISS Professional Education

Find your next eyecare job

Browse Eyecare Jobs (1,000+)Post a Job

Find your next eyecare job